CALR and acute myeloid leukemia: In this context, it was also demonstrated that for both mice and AML patients, CALR exposure on malignant blasts stimulates anticancer immunity through type I IFNs overproduction, which activates the cytotoxic action of T and NK cells inducing the innate and adaptative immune responses [61].